Uniphar (LON:UPR) Sets New 12-Month High – Still a Buy?

Uniphar plc (LON:UPRGet Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as GBX 420 and last traded at GBX 420, with a volume of 46936 shares traded. The stock had previously closed at GBX 418.

Uniphar Trading Up 0.5%

The company has a debt-to-equity ratio of 159.99, a quick ratio of 0.60 and a current ratio of 0.99. The firm has a market cap of £1.09 billion, a PE ratio of 21.54 and a beta of 1.13. The stock has a 50-day simple moving average of GBX 371.96 and a two-hundred day simple moving average of GBX 342.82.

Uniphar Company Profile

(Get Free Report)

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

Featured Articles

Receive News & Ratings for Uniphar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uniphar and related companies with MarketBeat.com's FREE daily email newsletter.